Ragaliauskas Tadas, Mickevicius Mindaugas, Budvytyte Rima, Niaura Gediminas, Carbonnier Benjamin, Valincius Gintaras
Institute of Biochemistry, Vilnius University, Mokslininku 12, LT-08662 Vilnius, Lithuania.
Institut de Chimie et des Matériaux Paris-Est, Université Paris-Est, 2 rue Henri Dunant, 94320 Thiais, France.
J Colloid Interface Sci. 2014 Jul 1;425:159-67. doi: 10.1016/j.jcis.2014.03.042. Epub 2014 Mar 25.
β-Amyloid oligomers of different aggregation and physiological functions exhibit distinct adsorption behavior allowing them to be discriminated in preparations.
Two forms of amyloid oligomers, small 1-4 nm and large 5-10nm were formulated using synthetic 42 amino acids β-amyloid peptide. Forms differ in their size and physiological function. A systematic study of adsorption of these amyloid species on self-assembled monolayers of octadecanethiol on gold was performed. Structural changes upon adsorption of oligomers were interrogated by the reflection absorption infrared spectroscopy.
The amount of adsorbed peptide material, as detected by surface plasmon resonance spectroscopy, is similar in case of both small and large oligomers. However, adsorption of small oligomers leads to a transformation from beta sheet rich to beta sheet depleted secondary structure. These changes were accompanied by the unique morphology patterns detectable by atomic force microscopy (AFM), while the quartz microbalance with dissipation indicated a formation of a compact adsorbate layer in case of small oligomers. These effects may be integrated and utilized in bioanalytical systems for sensing and detection of Alzheimer's disease related peptide forms in artificial, and possibly, real preparations.
具有不同聚集状态和生理功能的β-淀粉样蛋白寡聚体表现出不同的吸附行为,这使得它们在制剂中能够被区分开来。
使用合成的42个氨基酸的β-淀粉样肽制备了两种形式的淀粉样蛋白寡聚体,即小的1 - 4纳米和大的5 - 10纳米的寡聚体。这两种形式在大小和生理功能上有所不同。对这些淀粉样蛋白在金表面十八烷硫醇自组装单分子层上的吸附进行了系统研究。通过反射吸收红外光谱对寡聚体吸附后的结构变化进行了探究。
通过表面等离子体共振光谱检测发现,小寡聚体和大寡聚体吸附的肽物质的量相似。然而,小寡聚体的吸附导致了从富含β折叠到β折叠减少的二级结构转变。这些变化伴随着原子力显微镜(AFM)可检测到的独特形态模式,而石英晶体微天平与耗散监测表明,小寡聚体形成了致密的吸附层。这些效应可整合并应用于生物分析系统,用于在人工制剂甚至可能的实际制剂中传感和检测与阿尔茨海默病相关的肽形式。